QMV-12385-89005
1 vaccination
3 coded responses
3 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 633 / MO
- Registered
- 2022-09-01
- Relationship
- Child or adolescent in my care
- Guardian
- KHK-25480-66082
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-08-18
Dose 1 — Moderna
-
2022-09-01
Registered in v-safe
-
2022-09-01
Survey response — day 14, dose 1, under 3MedDRA: Cough, Exposure to SARS-CoV-2, Pyrexia, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend schoolFree text: Low grade fever, cough, congestion - we presume she has covid as I, her mother, have tested positiveMedDRA releases: 2024-11 · check-in free text available
-
2022-09-08
Survey response — day 21, dose 1, under 3MedDRA: Cough, Fatigue, Pyrexia, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend schoolFree text: Cough, low fever, congestion, fatigueMedDRA releases: 2024-11 · check-in free text available
-
2023-02-16
Survey response — 6 months, dose 1, under 3MedDRA: Cough, Exposure to SARS-CoV-2, Fatigue, Malaise, Pyrexia, Rhinorrhoea — Feeling: Fair · Be unable to work or attend schoolMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-08-18 | Moderna | No |
Free text
Release 12 (Under 3) — day 14, dose 1, under 3
Symptoms: Low grade fever, cough, congestion - we presume she has covid as I, her mother, have tested positive
Release 12 (Under 3) — day 21, dose 1, under 3
Symptoms: Cough, low fever, congestion, fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release